Skip to content

Combination of dexamethasone and dexmedetomidine as adjuvants of adductor canal block and IPACK block for postoperative analgesia in patients with total knee replacement: A randomized, double-blind controlled trial.

Combination of dexamethasone and dexmedetomidine as adjuvants of adductor canal block and IPACK block for postoperative analgesia in patients with total knee replacement: A randomized, double-blind controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094956
Enrollment
Unknown
Registered
2024-12-31
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

Dexamethasone Group:Administer 0.15mg/kg dexamethasone via intravenous infusion pump before performing the block
Dexamethasone And Dexmedetomidine Group:Before proceeding with the block, 0.15mg/kg dexamethasone is administered via intravenous infusion pump. After induction of general anesthesia, the researchers
Placebo Saline Group:Before the block, a placebo saline solution is administered via an intravenous infusion pump. After induction of general anesthesia, the researchers administer a placebo saline so

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who underwent unilateral TKA for osteoarthritis (OA), Planned ACB and IPACK blocks with intraoperative general anesthesia, were ASAI-III, had a body mass index of 18-30 kg/m^2, and were aged 18-80 years.

Exclusion criteria

Exclusion criteria: Impaired communication and understanding of language; peripheral neuropathy; known allergy to any study drug; patients who have taken analgesics and glucocorticoids in the past 3 months; or any contraindications to regional anesthesia, such as patient refusal, coagulopathy, or injection site infection; diabetes mellitus; severe liver or kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
The time from block to the first request for analgesia;

Secondary

MeasureTime frame
Postoperative pain scores at rest ;Postoperative pain scores during movement ;Cumulative postoperative morphine consumption;postoperative sleep quality;

Countries

China

Contacts

Public ContactHongfei Chen

The First Affiliated Hospital of Wenzhou Medical University

chhfei@126.com+86 136 9580 2515

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026